Showing results (351-360 of 366) with videos related to
Sort By:
Pageof 37
Nature Genetics|March 2, 2016
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170Alison M Dunning, Kyriaki Michailidou, Karoline B Kuchenbaecker, et al.Cancer Research|November 15, 2019
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and AggressivenessVivek L Patel, Evan L Busch, Tara M Friebel, et al.Nature Communications|April 28, 2016
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancerFergus J Couch, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.Genetic Epidemiology|March 3, 2020
Transcriptome-wide association study of breast cancer risk by estrogen-receptor statusHelian Feng, Alexander Gusev, Bogdan Pasaniuc, et al.Nature Communications|September 8, 2016
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locusKate Lawrenson, Siddhartha Kar, Karen McCue, et al.Nature Genetics|May 20, 2020
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analysesHaoyu Zhang, Thomas U Ahearn, Julie Lecarpentier, et al.European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.NPJ Breast Cancer|November 9, 2019
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerGisella Figlioli, Massimo Bogliolo, Irene Catucci, et al.Pageof 37